Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05761704
What this trial is testing

Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Second Affiliated Hospital, Zhejiang University, School of Medicine 54
Not applicableStudy completedNCT02982863
What this trial is testing

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 48,696
Large-scale testing (Phase 3)Ended earlyNCT03302494
What this trial is testing

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

Who this might be right for
Stroke
Coherex Medical 248
Large-scale testing (Phase 3)Study completedNCT00494871
What this trial is testing

Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 1,280
Not applicableUnknownNCT02906527
What this trial is testing

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Assistance Publique - Hôpitaux de Paris 150,000
Not applicableStudy completedNCT01774370
What this trial is testing

SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 3,182
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Not applicableStudy completedNCT03568916
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 227,579
Not applicableStudy completedNCT03684395
What this trial is testing

Accessibility to New Drugs Versus SOC in Sweden

Who this might be right for
Anticoagulation
Bayer 68,056
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableLooking for participantsNCT05598632
What this trial is testing

Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry

Who this might be right for
Atrial FibrillationStroke
China National Center for Cardiovascular Diseases 22,000
Not applicableStudy completedNCT05321810
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 193,565
Not applicableStudy completedNCT02344901
What this trial is testing

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Who this might be right for
Thrombotic StrokeAtrial Fibrillation and Flutter
Muğla Sıtkı Koçman University 6,273
Not applicableStudy completedNCT01476995
What this trial is testing

Prognostic Indicators as Provided by the EPIC ClearView

Who this might be right for
Coronary Artery DiseaseCongestive Heart FailureValvular Heart Disease+25 more
Epic Research & Diagnostics, Inc. 353
Not applicableStudy completedNCT05853250
What this trial is testing

Clinical and Hospital Stay Effects of Reiki and Manual Therapy After Open Heart Surgery

Who this might be right for
Coronary Artery DiseasesValvular Heart Diseases
The Cleveland Clinic 272
Not applicableWithdrawnNCT02153424
What this trial is testing

Early Post-marketing Study of Eliquis (Apixaban)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb
Not applicableStudy completedNCT03508271
What this trial is testing

Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

Who this might be right for
Atrial FibrillationHeart Failure
Bristol-Myers Squibb 60,000
Not applicableActive Not RecruitingNCT04010955
What this trial is testing

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Who this might be right for
Acute Ischemic StrokeAtrial FibrillationExtracranial Atherosclerosis+5 more
Asan Medical Center 1,200
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Not applicableStudy completedNCT04096963
What this trial is testing

Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

Who this might be right for
Non-valvular Atrial Fibrillation
Boston Scientific Corporation 50
Next Page